EP Patent

EP2486913A1 — Rapidly disintegrating oral film formulation for Olanzapin

Assigned to Labtec GmbH · Expires 2012-08-15 · 14y expired

What this patent protects

An orally disintegrating film (ODF) which comprises olanzapine or a salt or solvate thereof, polyvinyl alcohol, polyethylene glycol, one or more plasticizers and whereas at least one of the plasticisers is not PEG1000.

USPTO Abstract

An orally disintegrating film (ODF) which comprises olanzapine or a salt or solvate thereof, polyvinyl alcohol, polyethylene glycol, one or more plasticizers and whereas at least one of the plasticisers is not PEG1000.

Drugs covered by this patent

Patent Metadata

Patent number
EP2486913A1
Jurisdiction
EP
Classification
—
Expires
2012-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Labtec GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.